These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 22310089

  • 1. Highly potent delivery method of gp160 envelope vaccine combining lentivirus-like particles and DNA electrotransfer.
    Vandermeulen G, Athanasopoulos T, Trundley A, Foster K, Préat V, Yáñez-Muñoz RJ, Dickson G.
    J Control Release; 2012 May 10; 159(3):376-83. PubMed ID: 22310089
    [Abstract] [Full Text] [Related]

  • 2. Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons.
    Vinner L, Nielsen HV, Bryder K, Corbet S, Nielsen C, Fomsgaard A.
    Vaccine; 1999 Apr 23; 17(17):2166-75. PubMed ID: 10367950
    [Abstract] [Full Text] [Related]

  • 3. Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses.
    Bråve A, Hallengärd D, Malm M, Blazevic V, Rollman E, Stanescu I, Krohn K.
    Vaccine; 2009 Jan 07; 27(2):184-6. PubMed ID: 18992294
    [Abstract] [Full Text] [Related]

  • 4. [Immunogenicity of plasmid DNA and adenoviral vectors encoding HIV-1 subtype B env gene].
    Yang HR, Zhang LF, Feng X, Yu SQ, Zhuang ZL, Li HX, Zeng Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec 07; 24(6):415-7. PubMed ID: 21604562
    [Abstract] [Full Text] [Related]

  • 5. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
    Kaneko H, Bednarek I, Wierzbicki A, Kiszka I, Dmochowski M, Wasik TJ, Kaneko Y, Kozbor D.
    Virology; 2000 Feb 01; 267(1):8-16. PubMed ID: 10648178
    [Abstract] [Full Text] [Related]

  • 6. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine.
    Wingard JB, Anderson B, Weissman D.
    Eur J Immunol; 2008 May 01; 38(5):1310-20. PubMed ID: 18412164
    [Abstract] [Full Text] [Related]

  • 7. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
    McBurney SP, Young KR, Ross TM.
    Virology; 2007 Feb 20; 358(2):334-46. PubMed ID: 17011011
    [Abstract] [Full Text] [Related]

  • 8. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.
    Buonaguro L, Devito C, Tornesello ML, Schröder U, Wahren B, Hinkula J, Buonaguro FM.
    Vaccine; 2007 Aug 10; 25(32):5968-77. PubMed ID: 17629365
    [Abstract] [Full Text] [Related]

  • 9. Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery.
    Bråve A, Ljungberg K, Boberg A, Rollman E, Isaguliants M, Lundgren B, Blomberg P, Hinkula J, Wahren B.
    Mol Ther; 2005 Dec 10; 12(6):1197-205. PubMed ID: 16112909
    [Abstract] [Full Text] [Related]

  • 10. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.
    Akahata W, Yang ZY, Nabel GJ.
    J Virol; 2005 Jan 10; 79(1):626-31. PubMed ID: 15596858
    [Abstract] [Full Text] [Related]

  • 11. Contribution of the rev gene to the immunogenicity of DNA vaccines targeting the envelope glycoprotein of HIV.
    Jounai N, Okuda K, Kojima Y, Toda Y, Hamajima K, Ohba K, Klinman D, Xin KQ.
    J Gene Med; 2003 Jul 10; 5(7):609-17. PubMed ID: 12825200
    [Abstract] [Full Text] [Related]

  • 12. Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses.
    Megati S, Garcia-Hand D, Cappello S, Roopchand V, Masood A, Xu R, Luckay A, Chong SY, Rosati M, Sackitey S, Weiner DB, Felber BK, Pavlakis GN, Israel ZR, Smith LR, Eldridge JH, Sidhu MK, Egan MA.
    Vaccine; 2008 Sep 19; 26(40):5083-94. PubMed ID: 18485543
    [Abstract] [Full Text] [Related]

  • 13. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F, Rodríguez JR, Garzón A, Rodríguez D, Esteban M.
    Virus Res; 2006 Mar 19; 116(1-2):11-20. PubMed ID: 16214252
    [Abstract] [Full Text] [Related]

  • 14. Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo.
    Muthumani K, Zhang D, Dayes NS, Hwang DS, Calarota SA, Choo AY, Boyer JD, Weiner DB.
    Virology; 2003 Sep 15; 314(1):134-46. PubMed ID: 14517067
    [Abstract] [Full Text] [Related]

  • 15. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K, Forman J, Kräusslich HG, Rose JK.
    Virology; 2000 Mar 01; 268(1):112-21. PubMed ID: 10683333
    [Abstract] [Full Text] [Related]

  • 16. DNA prime/protein boost immunization against HIV clade C: safety and immunogenicity in mice.
    Rasmussen RA, Ong H, Kittel C, Ruprecht CR, Ferrantelli F, Hu SL, Polacino P, McKenna J, Moon J, Travis B, Ruprecht RM.
    Vaccine; 2006 Mar 20; 24(13):2324-32. PubMed ID: 16406147
    [Abstract] [Full Text] [Related]

  • 17. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
    Shinoda K, Xin KQ, Kojima Y, Saha S, Okuda K, Okuda K.
    Clin Immunol; 2006 Apr 20; 119(1):32-7. PubMed ID: 16458074
    [Abstract] [Full Text] [Related]

  • 18. Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies.
    Rollman E, Hinkula J, Arteaga J, Zuber B, Kjerrström A, Liu M, Wahren B, Ljungberg K.
    Gene Ther; 2004 Jul 20; 11(14):1146-54. PubMed ID: 15103320
    [Abstract] [Full Text] [Related]

  • 19. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W, Ren L, Jin N.
    J Virol Methods; 2007 Dec 20; 146(1-2):266-73. PubMed ID: 17868910
    [Abstract] [Full Text] [Related]

  • 20. Technology evaluation: HIVAC-1e.
    Zheng R.
    Curr Opin Mol Ther; 1999 Feb 20; 1(1):121-5. PubMed ID: 11249677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.